Similar results have been described in neuroblastoma, where MYCN-amplified cells display a distinct metabolic structure defined by high energy consumption and production compared to MYCN non-amplified neuroblastoma cells (93, 94). This evidence concerns the gene MYCN and neuroblastoma.